Parametrica Management LTD Gilead Sciences, Inc. Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $1.5 Million - $1.74 Million	-20,728 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.3 Million - $1.66 Million	20,728 New	20,728 $1.55 Million
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $750,922 - $841,230	-12,009 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $727,024 - $948,711	12,009 New	12,009 $751,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $300,319 - $366,122	-4,123 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $293,351 - $344,352	4,123	4,123 $295,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.